Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Plasma cell 2Gastrointestinal 2Thoracic 1Lymphoid 1CNS 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Alzheimer Disease 1

Interventions

Cyclophosphamide 10fludarabine 8Dexamethasone 8Lenalidomide 6Bortezomib 5Granulocyte Colony-Stimulating Factor 468Ga-pentixafor 4Melphalan 3Filgrastim 3Positron Emission Tomography Computed Tomography 2Fluorodeoxyglucose F18 2Blood Specimen Collection 2tocilizumab 1selinexor 1ruxolitinib 1pomalidomide 1pembrolizumab 1methyl prednisolonate 1ixazomib 1ioversol 1inebilizumab 1iberdomide 1fludarabine phosphate 1eltrombopag 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Blood Specimen Collection × Plasma cell × Clear all
NCT03804424 2024-11-12

64Cu-LLP2A for Imaging Multiple Myeloma

Washington University School of Medicine

Phase EARLY_PHASE1 Terminated
10 enrolled
Plasma cell

Multiple Myeloma

NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Samus Therapeutics, Inc.

Phase EARLY_PHASE1 Terminated
5 enrolled
LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡